nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—FPR1—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—bile duct cancer	0.0469	0.0555	CbGpPWpGaD
Nedocromil—HSP90AA1—gall bladder—bile duct cancer	0.046	0.298	CbGeAlD
Nedocromil—PTGDR—Prostaglandin Synthesis and Regulation—PTGS2—bile duct cancer	0.0334	0.0395	CbGpPWpGaD
Nedocromil—PTGDR—lymph node—bile duct cancer	0.0269	0.174	CbGeAlD
Nedocromil—CYSLTR1—pancreas—bile duct cancer	0.0244	0.158	CbGeAlD
Nedocromil—HSP90AA1—ErbB receptor signaling network—ERBB2—bile duct cancer	0.0232	0.0275	CbGpPWpGaD
Nedocromil—FPR1—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—bile duct cancer	0.0232	0.0274	CbGpPWpGaD
Nedocromil—HSP90AA1—pancreas—bile duct cancer	0.0212	0.137	CbGeAlD
Nedocromil—PTGDR—G alpha (s) signalling events—GNAS—bile duct cancer	0.02	0.0237	CbGpPWpGaD
Nedocromil—FPR1—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—bile duct cancer	0.0191	0.0226	CbGpPWpGaD
Nedocromil—FPR1—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—bile duct cancer	0.0188	0.0222	CbGpPWpGaD
Nedocromil—HSP90AA1—LKB1 signaling events—SMAD4—bile duct cancer	0.0179	0.0211	CbGpPWpGaD
Nedocromil—HSP90AA1—ErbB receptor signaling network—EGFR—bile duct cancer	0.0161	0.0191	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by constitutively active EGFR—NRAS—bile duct cancer	0.0146	0.0173	CbGpPWpGaD
Nedocromil—PTGDR—Thromboxane A2 receptor signaling—EGFR—bile duct cancer	0.0144	0.017	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrins in angiogenesis—TGFBR2—bile duct cancer	0.0139	0.0165	CbGpPWpGaD
Nedocromil—HSP90AA1—liver—bile duct cancer	0.0135	0.0874	CbGeAlD
Nedocromil—HSP90AA1—Signaling by constitutively active EGFR—EGFR—bile duct cancer	0.0133	0.0158	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ROBO2—bile duct cancer	0.0128	0.0151	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by constitutively active EGFR—KRAS—bile duct cancer	0.0126	0.0149	CbGpPWpGaD
Nedocromil—FPR1—G alpha (i) signalling events—GNAS—bile duct cancer	0.0124	0.0147	CbGpPWpGaD
Nedocromil—CYSLTR1—lymph node—bile duct cancer	0.0119	0.0772	CbGeAlD
Nedocromil—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—bile duct cancer	0.0112	0.0132	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—SMAD4—bile duct cancer	0.011	0.013	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by constitutively active EGFR—HRAS—bile duct cancer	0.0107	0.0127	CbGpPWpGaD
Nedocromil—HSP90AA1—lymph node—bile duct cancer	0.0103	0.067	CbGeAlD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.00992	0.0117	CbGpPWpGaD
Nedocromil—HSP90AA1—Semaphorin interactions—MET—bile duct cancer	0.00961	0.0114	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00927	0.011	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ROBO2—bile duct cancer	0.0091	0.0108	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—SLC5A5—bile duct cancer	0.00882	0.0104	CbGpPWpGaD
Nedocromil—CYSLTR2—Endothelins—HRAS—bile duct cancer	0.00825	0.00975	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—GNAS—bile duct cancer	0.00752	0.00889	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events—NRAS—bile duct cancer	0.00734	0.00868	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—GNAS—bile duct cancer	0.00726	0.00859	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00722	0.00853	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—TGFBR2—bile duct cancer	0.00711	0.0084	CbGpPWpGaD
Nedocromil—HSP90AA1—Semaphorin interactions—ERBB2—bile duct cancer	0.00702	0.0083	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00671	0.00793	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00657	0.00777	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00657	0.00777	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—HGF—bile duct cancer	0.00653	0.00772	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events—KRAS—bile duct cancer	0.00632	0.00747	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00621	0.00734	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—MMP2—bile duct cancer	0.00611	0.00722	CbGpPWpGaD
Nedocromil—HSP90AA1—LKB1 signaling events—TP53—bile duct cancer	0.00583	0.00689	CbGpPWpGaD
Nedocromil—CYSLTR1—Endothelins—HRAS—bile duct cancer	0.00572	0.00676	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—GNAS—bile duct cancer	0.0057	0.00674	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events—HRAS—bile duct cancer	0.00537	0.00635	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00528	0.00624	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—MMP9—bile duct cancer	0.00528	0.00624	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—RNF43—bile duct cancer	0.00517	0.00612	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—RNF43—bile duct cancer	0.005	0.00591	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—TGFB1—bile duct cancer	0.0049	0.0058	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—EGFR—bile duct cancer	0.00481	0.00569	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—FAR2—bile duct cancer	0.00478	0.00565	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—MMP9—bile duct cancer	0.00459	0.00543	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—GNAS—bile duct cancer	0.00425	0.00503	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.00422	0.00499	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—NRAS—bile duct cancer	0.00414	0.0049	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—GNAS—bile duct cancer	0.00411	0.00485	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—GNAS—bile duct cancer	0.00395	0.00467	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RNF43—bile duct cancer	0.00392	0.00463	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—GNAS—bile duct cancer	0.00386	0.00456	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.00385	0.00455	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	0.00385	0.00455	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—GNAS—bile duct cancer	0.00373	0.00441	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—NRAS—bile duct cancer	0.00367	0.00434	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.00364	0.0043	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—bile duct cancer	0.00358	0.00423	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—KRAS—bile duct cancer	0.00357	0.00422	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.00348	0.00411	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—NRAS—bile duct cancer	0.00347	0.0041	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—ERBB2—bile duct cancer	0.00345	0.00408	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—GNAS—bile duct cancer	0.00322	0.00381	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.00318	0.00376	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—ERBB2—bile duct cancer	0.00317	0.00375	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.00316	0.00374	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.00309	0.00365	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—HRAS—bile duct cancer	0.00303	0.00358	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—KRAS—bile duct cancer	0.00298	0.00353	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—HRAS—bile duct cancer	0.00298	0.00352	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.00296	0.0035	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.00293	0.00346	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—GNAS—bile duct cancer	0.00293	0.00346	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—IL6—bile duct cancer	0.0029	0.00343	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RNF43—bile duct cancer	0.00279	0.00329	CbGpPWpGaD
Nedocromil—HSP90AA1—Influenza Infection—TGFB1—bile duct cancer	0.00274	0.00324	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MET—bile duct cancer	0.00272	0.00322	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RNF43—bile duct cancer	0.00272	0.00321	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.00269	0.00318	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	0.00267	0.00315	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—TGFB1—bile duct cancer	0.00266	0.00315	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—NRAS—bile duct cancer	0.00262	0.0031	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.00257	0.00304	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—SMAD4—bile duct cancer	0.00254	0.003	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—bile duct cancer	0.00254	0.003	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.00252	0.00298	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—IL6—bile duct cancer	0.00243	0.00287	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—NRAS—bile duct cancer	0.00241	0.00285	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IDH1—bile duct cancer	0.00239	0.00283	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—bile duct cancer	0.00239	0.00283	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFBR2—bile duct cancer	0.00236	0.00279	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—IDH2—bile duct cancer	0.00233	0.00276	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFBR2—bile duct cancer	0.00228	0.0027	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GNAS—bile duct cancer	0.00228	0.0027	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MMP2—bile duct cancer	0.00227	0.00268	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—KRAS—bile duct cancer	0.00226	0.00267	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SMAD4—bile duct cancer	0.00224	0.00265	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GNAS—bile duct cancer	0.00223	0.00264	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GNAS—bile duct cancer	0.0022	0.0026	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—bile duct cancer	0.0022	0.0026	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SMAD4—bile duct cancer	0.00216	0.00255	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.00214	0.00253	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—KRAS—bile duct cancer	0.00208	0.00245	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.00205	0.00242	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GNAS—bile duct cancer	0.00203	0.0024	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—IDH1—bile duct cancer	0.00201	0.00237	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ERBB2—bile duct cancer	0.00199	0.00235	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RNF43—bile duct cancer	0.00195	0.00231	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MET—bile duct cancer	0.00194	0.0023	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—bile duct cancer	0.00192	0.00227	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—IL6—bile duct cancer	0.00184	0.00217	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFBR2—bile duct cancer	0.00179	0.00212	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.00176	0.00209	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GNAS—bile duct cancer	0.00173	0.00204	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MMP9—bile duct cancer	0.00171	0.00202	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SMAD4—bile duct cancer	0.0017	0.002	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.00169	0.002	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP2—bile duct cancer	0.00162	0.00192	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—NRAS—bile duct cancer	0.00161	0.00191	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—NRAS—bile duct cancer	0.00156	0.00184	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—NRAS—bile duct cancer	0.00151	0.00179	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—bile duct cancer	0.00147	0.00174	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ERBB2—bile duct cancer	0.00142	0.00168	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—bile duct cancer	0.00142	0.00168	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—KRAS—bile duct cancer	0.00139	0.00164	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—bile duct cancer	0.00138	0.00163	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—bile duct cancer	0.00136	0.00161	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—KRAS—bile duct cancer	0.00134	0.00159	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC5A5—bile duct cancer	0.00132	0.00156	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—KRAS—bile duct cancer	0.0013	0.00154	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFBR2—bile duct cancer	0.00127	0.0015	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HGF—bile duct cancer	0.00127	0.0015	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ERBB2—bile duct cancer	0.00125	0.00148	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ERBB2—bile duct cancer	0.00125	0.00148	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—bile duct cancer	0.00125	0.00148	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFBR2—bile duct cancer	0.00124	0.00147	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—NRAS—bile duct cancer	0.00122	0.00145	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP9—bile duct cancer	0.00122	0.00144	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ERBB2—bile duct cancer	0.00121	0.00143	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SMAD4—bile duct cancer	0.0012	0.00142	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNAS—bile duct cancer	0.0012	0.00142	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRAS—bile duct cancer	0.00118	0.0014	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SMAD4—bile duct cancer	0.00118	0.00139	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—bile duct cancer	0.00114	0.00135	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—bile duct cancer	0.00113	0.00134	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—bile duct cancer	0.00111	0.00132	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—bile duct cancer	0.00111	0.00131	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—bile duct cancer	0.00109	0.00129	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NRAS—bile duct cancer	0.00108	0.00128	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—bile duct cancer	0.00107	0.00127	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—bile duct cancer	0.00106	0.00125	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—KRAS—bile duct cancer	0.00105	0.00124	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—bile duct cancer	0.00104	0.00123	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNAS—bile duct cancer	0.00103	0.00122	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—bile duct cancer	0.001	0.00119	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—bile duct cancer	0.000984	0.00116	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—NRAS—bile duct cancer	0.000954	0.00113	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NRAS—bile duct cancer	0.000953	0.00113	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ERBB2—bile duct cancer	0.000949	0.00112	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KRAS—bile duct cancer	0.00093	0.0011	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NRAS—bile duct cancer	0.00092	0.00109	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS2—bile duct cancer	0.000897	0.00106	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—bile duct cancer	0.000894	0.00106	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFBR2—bile duct cancer	0.000891	0.00105	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—bile duct cancer	0.000885	0.00105	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—bile duct cancer	0.000869	0.00103	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—bile duct cancer	0.000868	0.00103	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNAS—bile duct cancer	0.00086	0.00102	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—bile duct cancer	0.000856	0.00101	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—bile duct cancer	0.000855	0.00101	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—NRAS—bile duct cancer	0.000847	0.001	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SMAD4—bile duct cancer	0.000844	0.000997	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—bile duct cancer	0.000838	0.000991	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KRAS—bile duct cancer	0.000821	0.000971	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KRAS—bile duct cancer	0.00082	0.00097	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—bile duct cancer	0.000814	0.000963	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KRAS—bile duct cancer	0.000792	0.000936	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—bile duct cancer	0.00079	0.000934	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—bile duct cancer	0.000772	0.000913	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—bile duct cancer	0.000765	0.000904	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—bile duct cancer	0.000756	0.000894	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ERBB2—bile duct cancer	0.00073	0.000864	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—KRAS—bile duct cancer	0.000729	0.000862	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—bile duct cancer	0.000729	0.000862	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NRAS—bile duct cancer	0.000722	0.000854	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—bile duct cancer	0.000704	0.000832	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—bile duct cancer	0.000698	0.000825	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—bile duct cancer	0.000697	0.000824	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERBB2—bile duct cancer	0.000674	0.000797	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—bile duct cancer	0.000673	0.000796	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—bile duct cancer	0.000671	0.000793	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—bile duct cancer	0.000668	0.00079	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—bile duct cancer	0.000667	0.000789	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—bile duct cancer	0.000659	0.00078	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ERBB2—bile duct cancer	0.000658	0.000778	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—bile duct cancer	0.000658	0.000778	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—bile duct cancer	0.000644	0.000762	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KRAS—bile duct cancer	0.000621	0.000735	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—bile duct cancer	0.00062	0.000733	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—bile duct cancer	0.000593	0.000701	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—bile duct cancer	0.000564	0.000667	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NRAS—bile duct cancer	0.000556	0.000657	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—bile duct cancer	0.000552	0.000653	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—bile duct cancer	0.000552	0.000653	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—bile duct cancer	0.000528	0.000625	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NRAS—bile duct cancer	0.000513	0.000607	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—bile duct cancer	0.000506	0.000599	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—bile duct cancer	0.000506	0.000598	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NRAS—bile duct cancer	0.0005	0.000592	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KRAS—bile duct cancer	0.000478	0.000565	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—bile duct cancer	0.000477	0.000564	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ERBB2—bile duct cancer	0.000472	0.000558	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—bile duct cancer	0.000467	0.000553	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—bile duct cancer	0.000465	0.00055	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—bile duct cancer	0.000456	0.000539	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KRAS—bile duct cancer	0.000442	0.000522	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KRAS—bile duct cancer	0.000431	0.000509	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—bile duct cancer	0.000407	0.000481	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—bile duct cancer	0.000405	0.000479	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—bile duct cancer	0.000389	0.00046	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—bile duct cancer	0.000383	0.000453	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—bile duct cancer	0.000375	0.000444	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—bile duct cancer	0.000366	0.000433	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NRAS—bile duct cancer	0.000359	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—bile duct cancer	0.000359	0.000425	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—bile duct cancer	0.00035	0.000414	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—bile duct cancer	0.000334	0.000395	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—bile duct cancer	0.000327	0.000387	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KRAS—bile duct cancer	0.000309	0.000366	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—bile duct cancer	0.000275	0.000325	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—bile duct cancer	0.000263	0.000311	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—bile duct cancer	0.000252	0.000297	CbGpPWpGaD
